HomeDCOY • NASDAQ
add
Decoy Therapeutics Inc
Previous close
$6.27
Day range
$5.60 - $6.48
Year range
$5.60 - $16.92
Market cap
3.09M USD
Avg Volume
25.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 516.60K | -65.30% |
Net income | -8.98M | -513.26% |
Net profit margin | — | — |
Earnings per share | 43.10 | — |
EBITDA | -512.76K | 65.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.71M | 339.92% |
Total assets | 11.06M | 265.76% |
Total liabilities | 5.17M | 241.94% |
Total equity | 5.89M | — |
Shares outstanding | 531.97K | — |
Price to book | 0.57 | — |
Return on assets | -15.06% | — |
Return on capital | -25.48% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.98M | -513.26% |
Cash from operations | -1.14M | -53.06% |
Cash from investing | 964.74K | — |
Cash from financing | 6.07M | 5,775.68% |
Net change in cash | 5.90M | 794.56% |
Free cash flow | 3.90M | 1,965.86% |
About
Founded
2014
Headquarters
Website
Employees
2
